Дисертації з теми "Diabetic management"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 дисертацій для дослідження на тему "Diabetic management".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте дисертації для різних дисциплін та оформлюйте правильно вашу бібліографію.
Davies, B. "Painful diabetic neuropathy : exploring management options." Thesis, University of the West of England, Bristol, 2017. http://eprints.uwe.ac.uk/31786/.
Повний текст джерелаFuller, Caroline Anne. "Diabetic diet management : a native Indian perspective." Thesis, University of British Columbia, 1991. http://hdl.handle.net/2429/29707.
Повний текст джерелаApplied Science, Faculty of
Nursing, School of
Graduate
Dang, Cuong Nguyen. "Aetiopathogenesis and Management of Diabetic Foot Problems." Thesis, University of Manchester, 2009. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.512177.
Повний текст джерелаOyibo, Samson Oghenetsovwe. "Studies on the management of diabetic foot problems." Thesis, University of Manchester, 2004. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.557096.
Повний текст джерелаQuinton, T. R., P. A. Lazzarini, F. M. Boyle, A. W. Russell, and D. G. Armstrong. "How do Australian podiatrists manage patients with diabetes? The Australian diabetic foot management survey." BioMed Central, 2015. http://hdl.handle.net/10150/610321.
Повний текст джерелаMcEwen, Marylyn Morris, Rogelio Andrès Elizondo-Pereo, Alice E. Pasvogel, Irene Meester, Javier Vargas-Villarreal, and Francisco González-Salazar. "A Modified Behavior Risk Factor Surveillance System to Assess Diabetes Self-management Behaviors and Diabetes Care in Monterrey Mexico: A Cross-sectional Study." FRONTIERS MEDIA SA, 2017. http://hdl.handle.net/10150/625711.
Повний текст джерелаHill, C. "Diabetic kidney disease : a study of management and outcomes." Thesis, Queen's University Belfast, 2014. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.676518.
Повний текст джерелаYan, Min, and 严敏. "Effects of self-management education on diabetic control among patients with type 2 diabetes : a systematic review." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2013. http://hdl.handle.net/10722/193810.
Повний текст джерелаpublished_or_final_version
Public Health
Master
Master of Public Health
Vora, Sadhna Raju. "Multiple Laser Photocoagulation Treatments for the Management of Diabetic Macular Edema." Yale University, 2006. http://ymtdl.med.yale.edu/theses/available/etd-06282006-150918/.
Повний текст джерелаDzivakwe, Vanessa G. "Religiosity As a Coping Resource for Depression and Disease Management Among Older Diabetic Patients." Thesis, University of North Texas, 2014. https://digital.library.unt.edu/ark:/67531/metadc700076/.
Повний текст джерелаCagle, Jonathan. "After receiving language concordant, individual health education interventions, do Spanish speaking, diabetic inpatients at a safety net hospital demonstrate acquired diabetes self-management competency as measured by pre-training and post training evaluation of key, diabetes self-management knowledge?" Thesis, The University of Arizona, 2018. http://hdl.handle.net/10150/626844.
Повний текст джерелаSando, Trisha A. "The Influence of Clinically Meaningful Factors on the Performance of the Recommended Annual Diabetic Foot Screening." VCU Scholars Compass, 2018. https://scholarscompass.vcu.edu/etd/5323.
Повний текст джерелаLeontidis, Georgios. "Early screening and diagnosis of diabetic retinopathy." Thesis, University of Lincoln, 2016. http://eprints.lincoln.ac.uk/26473/.
Повний текст джерелаLuttig, Jana. "Evaluation and management of diabetic patients in a primary healthcare clinic / Jana Luttig." Thesis, North-West University, 2007. http://hdl.handle.net/10394/1834.
Повний текст джерелаThesis (M.Pharm. (Pharmacy Practice))--North-West University, Potchefstroom Campus, 2008.
Williams, Gareth. "Investigation and management of brittle diabetic patients unresponsive to continuous subcutaneous insulin infusion." Thesis, University of Cambridge, 1986. https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.685001.
Повний текст джерелаJyothi, Sreedhar. "Current and new concepts in the diagnosis and management of diabetic macular oedema." Thesis, Cranfield University, 2013. http://dspace.lib.cranfield.ac.uk/handle/1826/8600.
Повний текст джерелаGarrison, Melissa Sue. "A Proposal for the Development and Validation of a Diabetic Self-Management Education (DSME) Program." ScholarWorks, 2015. https://scholarworks.waldenu.edu/dissertations/354.
Повний текст джерелаScarlett, Marjorie V. "Evidence-Based Diabetic Discharge Guideline| A Standardized Initiative to Promote Nurses' Adherence." Thesis, Nova Southeastern University, 2018. http://pqdtopen.proquest.com/#viewpdf?dispub=10685982.
Повний текст джерелаBackground: Diabetes mellitus (DM) affects more than 29.1 million Americans. Standardized clinical practice guidelines recommended by regulatory healthcare agencies are the standard of care for diabetic patients and must be adhered to by healthcare professionals providing care.
Purpose: The purpose of this quality improvement project was to identify Centers for Medicare and Medicaid Services’, Joint Commission on Accreditation of Healthcare Organization’s, and other professional healthcare organizations’ guidelines for nurses’ knowledge of evidence-based discharge practices; determine level of nurses’ knowledge on evidence-based discharge practice process; develop a quality improvement plan, including development of an evidence-based guideline for diabetic discharge instructions; present guideline to stakeholders; implement the guideline in fall of 2017; and evaluate nursing compliance with the guideline at a for-profit adult care hospital in South Florida.
Theoretical Framework: The chronic care model was utilized as the framework. This model has been used for improving practice and preventing many chronic illnesses.
Methods: Two quantitative nonparametric descriptive designs were used, the Wilcoxon signed- rank test and a paired t test. An online demographic survey and pre- and posttest surveys were administered to determine nurses’ knowledge of diabetes discharge guideline practices. The Appraisal of Guidelines for Research and Evaluation II (AGREE II) evaluation tool evaluated the guideline, and data were analyzed with Wilcoxon and paired t tests.
Results: A statistically significant difference was found in the pre-posttest survey responses for question 5 (p = 0.046 Wilcoxon; p = 0.041t test), and question 13 (p = 0.022 Wilcoxon; p = 0.018 t test), indicating improvement. With the AGREE II tool, the multidisciplinary team evaluated the guideline at 100%, and 76% of Advanced Practice Registered Nurses (APRNs) and Registered Nurses (RNs) demonstrated compliance with guideline use.
Conclusion: A standardized diabetic discharge guideline incorporated into the hospital’s discharge process provided APRNs and RNs with tools for educating and providing diabetic patients for increase in quality of life after discharge. The guideline was recommended by the administrative team for continued use throughout the hospital. Implementation of an evidence-based standardized diabetic discharge guideline to promote nurses’ adherence results in effective nursing practices and an informed patient population.
Fourie, René. "Registered nurses' knowledge related to the management of patients with diabetic keto-acidosis (DKA)." Thesis, Nelson Mandela Metropolitan University, 2006. http://hdl.handle.net/10948/448.
Повний текст джерелаFang, Lei. "Development and Characterization of an Iridium-Modified Electrochemical Biosensor for Potential Diabetic Patient Management." Cleveland, Ohio : Case Western Reserve University, 2009. http://rave.ohiolink.edu/etdc/view?acc_num=case1223049333.
Повний текст джерелаDepartment of Chemical Engineering Abstract Title from OhioLINK abstract screen (viewed on 10 April 2009) Available online via the OhioLINK ETD Center
Okafor, Eugene O. "Decreasing Acute Diabetes Complications Through Self-Management Education." ScholarWorks, 2018. https://scholarworks.waldenu.edu/dissertations/5922.
Повний текст джерелаBahremand, Saeid. "Blood Glucose Management Streptozotocin-Induced Diabetic Rats by Artificial Neural Network Based Model Predictive Control." Thesis, Southern Illinois University at Edwardsville, 2017. http://pqdtopen.proquest.com/#viewpdf?dispub=10249804.
Повний текст джерелаDiabetes is a group of metabolic diseases where the body’s pancreas does not produce enough insulin or does not properly respond to insulin produced, resulting in high blood sugar levels over a prolonged period. There are several different types of diabetes, but the most common forms are type 1 and type 2 diabetes. Type 1 diabetes Mellitus (T1DM) can occur at any age, but is most commonly diagnosed from infancy to late 30s. If a person is diagnosed with type 1 diabetes, their pancreas produces little to no insulin, and the body’s immune system destroys the insulin-producing cells in the pancreas. Those diagnosed with type 1 diabetes must inject insulin several times every day or continually infuse insulin through a pump, as well as manage their diet and exercise habits. If not treated appropriately, it can cause serious complications such as cardiovascular disease, stroke, kidney failure, foot ulcers, and damage to eyes.
During the past decade, researchers have developed artificial pancreas (AP) to ease management of diabetes. AP has three components: continuous glucose monitor (CGM), insulin pump, and closed-loop control algorithm. Researchers have developed algorithms based on control techniques such as Proportional Integral Derivative (PID) and Model Predictive Control (MPC) for blood glucose level (BGL) control; however, variability in metabolism between or within individuals hinders reliable control.
This study aims to develop an adaptive algorithm using Artificial Neural Networks (ANN) based Model Predictive Control (NN-MPC) to perform proper insulin injections according to BGL predictions in diabetic rats. This study is a ground work to implement NN-MPC algorithm on real subjects. BGL data collected from diabetic rats using CGM are used with other inputs such as insulin injection and meal information to develop a virtual plant model based on a mathematical model of glucose–insulin homeostasis proposed by Lombarte et al. Since this model is proposed for healthy rats; a revised version on this model with three additional equations representing diabetic rats is used to generate data for training ANN which is applicable for the identi?cation of dynamics and the glycemic regulation of rats. The trained ANN is coupled with MPC algorithm to control BGL of the plant model within the normal range of 100 to 130 mg/dl by injecting appropriate amount of insulin. The ANN performed well with less than 5 mg/dl error (2%) for 5-minute prediction and about 15 mg/dl error (7%) for 30-minute prediction. In ¬¬addition, the NN-MPC algorithm kept BGL of diabetic rats more than 90 percent of the time within the normal range without hyper/hypo-glycaemia.
Qadri, Sara Fatima. "Perceived Barriers of Adult Medicine Nurses for Providing Self-Management Education to Type 2 Diabetic Patients." The Ohio State University, 2014. http://rave.ohiolink.edu/etdc/view?acc_num=osu1388677153.
Повний текст джерелаPrimomo, Janet. "Patterns of chronic illness management, psychosocial development, family and social environment and adaptation among diabetic women /." Thesis, Connect to this title online; UW restricted, 1989. http://hdl.handle.net/1773/7227.
Повний текст джерелаCraig, Kathrine Jane. "Identification, investigation and management of patients with diabetic nepropathy at the primary and secondary care interface." Thesis, Cardiff University, 2007. http://orca.cf.ac.uk/55733/.
Повний текст джерелаSharma, Masti Venugopal Srihari. "Identification of diagnostic biomarkers to improve the management of diabetes-related foot ulcers." Thesis, Queensland University of Technology, 2018. https://eprints.qut.edu.au/116374/1/Masti%20Venugopal%20Srihari_Sharma_Thesis.pdf.
Повний текст джерелаMudumbi, John Baptist Nzukizi. "Bioaccumulation of Perfluoroalkyl Substances in African marigold (Tagetes erecta L.) used for Diabetes mellitus Management and in Diabetic Serum of a South African Population." Thesis, Cape Peninsula University of Technology, 2019. http://hdl.handle.net/20.500.11838/2990.
Повний текст джерелаPolyfluoroalkyl substances (PFASs), including perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) are anthropogenic chemicals. For more than half a century, these long-chain compounds have been used in a wide range of industrial applications, such as the manufacturing of consumer products, ranging from grease-proof food packing to aqueous fire-fighting foams and to stain repellents such as Teflon®. Subsequently, these ubiquitous contaminants which are environmentally persistent, toxic, and bioaccumulative, have been a focus of public concern worldwide. Hence, due to public health apprehensions and environmental risks posed by PFASs, their manufacturers and various environmental agencies decided on restricting their use, and whereby the use of these chemicals could not be stopped, their replacement by other alternative chemicals was suggested. Therefore, per- or polyfluorinated carbon chains, e.g. perfluorobutane sulfonate (PFBS), which has been regarded as one of the most important short-chain PFASs and less harmful to the environment at large. However, a systematic review from the current work reveals that physicochemical properties of short-chain PFASs are not different from their predecessors thus suggesting that short-chain PFASs are as harmful as their homologues. Similarly, the literature reviewed demonstrated how novel technologies have also been proven to be incapable of removing these substances, including to short-chain PFASs, from various environmental matrices. Moreover, plant species have extensively been susceptible to PFASs, and various other POPs accumulation. However, the mechanisms that led to their uptake and storage by plants stayed unknown until proteins belonging to the family of major intrinsic proteins (MIPs) and ater named as Aquaporins (AQPs) were discovered. Hence, the present work has reported that there are diverse AQPs in plants than in mammals, with specific functions, even though first reports on these proteins suggested that their significant impact was water for transportation only. To date, it is well known that plant AQPs possess subclasses or isoforms. Some of these include SoPIP2;1 and AtTIP2;1, prevalent in Spinacia oleracea and Arabidopsis thaliana, respectively. We report that these two isoforms have individual pore diameters or sizes: SoPIP2;1 (2.1 Å) and AtTIP2;1 (3 Å), which might play a role in the selectivity process of molecules which pass through the water transportation channels of the concerned plants. This ultimately suggested SoPIP2;1 pore diameter serving as a pathway of smaller molecules, while AtTIP2;1 pore diameter would serve as a conduit for both smaller and larger compounds. As such, the pore diameters of these two isoforms made them potential conduits of PFASs whose carbon–fluorine bond typical size is 1.35 Å, much smaller than that of AtTIP2;1_2.1 Å and PIP2s, i.e. SoPIP2;1_3 Å, thus substantiating the uptake and ultimate storage of PFASs by plant species. Subsequently, the uptake and storage of PFASs and other POPs by plants have been proven to lead to unprecedented environmental and human risks. As plants with the potential to heal or manage certain ailments, such as Diabetes mellitus (DM), when exposed to PFASs, it was necessary to substantiate such a phenomenon. This current study further determined the propensity of PFASs, such as PFOA, PFOS and PFBS, to accumulate in a plant commonly used in the management of DM, namely the African marigold (Tagetes erecta L.). The study was important as this plant is used in diabetes management in the Western Cape, South Africa, thus implying the plant being a pathway through which humans might be exposed to PFASs and its precursors. Accordingly, the target analytes of the study, PFOA, PFOS and PFBS, were identified and quantified in samples collected from the said plant, i.e. Tagetes erecta L., in contaminated river water used to irrigate the studied plant, as well as diabetic serum samples from patients likely to use the plant. The analysis was done using a liquid chromatography coupled with tandem mass spectrometry (Shimadzu LCMS-8030, Canby, OR, USA). The MS operational conditions were sourced with an MS interface electrospray ionisation in negative ion mode. A multiple reaction monitoring (MRM) mode of analysis was used to quantify the targeted PFASs in samples. Hence MRM transition for PFOA, PFOS and PFBS being of 413.00 > 368.95 (acquisition time: 8.6 min), 499.00 <80.15 (8.9 min) and 299.00 > 80.10 (6.8 min), respectively. A Luna® Omega Polar C18 column (2.1 × 100 mm, 3.0 µm, Phenomenex, Aschaffenburg, Germany), with 40 °C in temperature, assisted in the separation of the analytes. The mobile phase at a flow rate of 0.3 L/min was made of 20 mM ammonium acetate and MeOH (100%). The process followed (for solid samples, i.e. plants) (n = 8) was: 1) sample drying, 2) milling, 3) screening, 4) digestion, 5) sonication, 6) filtration, 7) Solid phase extraction (SPE), 8) analyte elution and 9) analysis; for water samples (n = 20) the process was: 1) filtration, 2) SPE, 3) analyte elution and 4) analysis; while for serum samples (n = 179) the process was: 1) sample uptake, 2) buffers, 3) Mix, 4) centrifuge, 5) Dissolve, 6) filtration, 7) SPE, 8) conditioning, 9) elution, 10) reconstitute, 11) analysis. PFOA, PFOS and PFBS were observed in all the plant samples and were found in concentrations of up to 94.83 ng/g, 5.03 ng/g, and 1.44 ng/g, for PFOA, PFOS and PFBS, respectively. Similarly, PFOA, PFOS and PFBS were identified in all the river water samples and were found in concentrations ranging between 1.15 to 107.82, 1.24 to 20.75 and ND to 0.06 ng/L for PFOA, PFBS and PFOS, respectively, for regime A (winter/wet season) and
Zhao, Wenxia (Helen). "Comorbidity in prediction of in-hospital mortality among diabetic patients: A study-derived index." Thesis, University of Ottawa (Canada), 2005. http://hdl.handle.net/10393/27100.
Повний текст джерелаBuhajeeh, Eman A. A. "Diabetes in Kuwait - current patients' experiences of their medical treatment(s) with emphasis on renal complications as compared with worldwide guidelines." Thesis, University of Bradford, 2015. http://hdl.handle.net/10454/14182.
Повний текст джерелаMills, David. "The role of goal setting in the diabetes case management of aboriginal and non-aboriginal populations in rural South Australia /." Title page, table of contents and abstract only, 2005. http://web4.library.adelaide.edu.au/theses/09MD/09mdm6571.pdf.
Повний текст джерелаIncludes publications published as a result of ideas developed in this thesis, inserted at end. "April 2005" Includes bibliographical references (leaves 210-242).
Ramasobane, Maureen Khanyisa Mlati. "A description of the knowledge, understanding and outcome of disease management in diabetic patients in dedicated, semi-dedicated and non-dedicated institutions." Thesis, University of Limpopo (Medunsa Campus), 2010. http://hdl.handle.net/10386/211.
Повний текст джерелаDiabetes Mellitus (DM) is a self -managed condition and it is essential for patients to have the relevant knowledge, skills and attitudes needed for successful diabetes management. Follow-up and proper counselling are major components in diabetes management as these will improve adherence and optimise diabetes management. The aim of this study was to compare the knowledge, understanding and outcome of the disease management in four health institutions ; a dedicated institution, a semi-dedicated institution and two non-dedicated institution. The study objectives were: To describe the level of knowledge and understanding of diabetic patients in the management of their condition at the different institutions , to describe the outcome of diabetes management at the different institutions , to describe consulting and dispensing times for diabetic patients at the different institutions , and to obtain patients’ perceptions on the quality of the health care services pertaining to the treatment of their diabetes. A total of 120 patients were interviewed, 30 per institution. A questionnaire was used to collect data for the different objectives. Prospective and retrospective data were collected. Knowledge of DM was assessed in ten patients from each institution. Patients were asked to explain their understanding on five aspects of the condition. Median scores for patients from the two non-dedicated institutions were compared using Wilcoxon two-sample test, and were found not to differ significantly for any of the questions or the overall score. The groups did not differ significantly in their understanding of whether there was a cure for diabetes mellitus and in their understanding of hypoglycaemia and its management. Patients at the dedicated clinic were significantly more knowledgeable of the condition, it’s causes and their overall understanding of the questions asked. Hyperglycaemia and its management were understood significantly better by the patients at the dedicated iv institution than those at the non-dedicated institutions , with patients at the semi-dedicated institution not differing significantly from either group. The outcome of diabetes management was recorded from the patients file for a six month period. The proportions of elevated blood pressure results recorded at the three institution types differed significantly. The semi-dedicated institution had a significantly higher proportion of uncontrolled blood pressure results (33 of 55 results recorded, or 60%) than the non-dedicated institutions (32 of 91, 35%) or the dedicated institution (9 of 36, 25%,). None of the ten patients at the semi-dedicated institution had all their values within the controlled range, as compared to six of 20 at the non-dedicated and six of ten at the dedicated institution. The glucose control was least achieved in patients at the semidedicated institution, where only one of ten (10%) of patients had no recorded value outside the controlled range, as opposed to four of ten (40%) at the dedicated institution and nine of eighteen (50%) at the non-dedicated institutions. Median visit times differed between all types of institutions. Time spent on consulting and dispensing was the shortest at the non-dedicated (median=7min), it took longer at the semi-dedicated (median=9), and longest at the dedicated institution (median=18min). The patient’s perception on the quality of care was recorded for patients. They were asked whether they were satisfied with the amount of time that they spent with the healthcare worker. Patient satisfaction with visit time was not linked to the duration of the visit. Actual visit time did appear to be linked to patients’ perception of whether they got enough time to ask questions. As for perceived quality of service, fewer patients were informed about their progress at the non-dedicated institution than at the others. Family members of fewer patients were educated at the dedicated than at the other institutions. More patients at the dedicated institution than at the other institutions were informed of treatment changes. Suggestions for improvement of patient care were made by 18% of v patients attending non-dedicated institutions , 23% of patients at the semi-dedicated institution and 63% at the dedicated institution. The conclusion based on the results is that the more dedicated a service is, the better the diabetic care of patients. Patients at the dedicated clinic had more time with the health worker during consultation and dispensing of treatment. They were informed about treatment changes more than the patients at other institutions. Patients at the dedicated clinic also showed a better knowledge and understanding of their condition than patients in other institutions. They also had higher affirmative responses in terms of lifestyle modification as compared to the other institutions.
Фадєєва, Ганна Анатоліївна, Анна Анатольевна Фадеева, Hanna Anatoliivna Fadieieva, and Ahmad L. Abbas. "Advantages of incretin-based treatment in management of type 2 diabetes." Thesis, Sumy state university, 2017. http://essuir.sumdu.edu.ua/handle/123456789/54972.
Повний текст джерелаNguyen, Vi H. "Will culturally competent Vietnamese-speaking healthcare providers reduce hemoglobin A1C-readings for Vietnamese diabetic patients?" Thesis, California State University, Long Beach, 2013. http://pqdtopen.proquest.com/#viewpdf?dispub=1524147.
Повний текст джерелаThis retrospective study was conducted to evaluate whether culturally competent resources, such as Vietnamese-speaking healthcare providers, one-on-one public health nurse (PHN) education session(s), and free healthcare services would affect the results of the following questions: (a) Will the 114 study subjects achieve HbAIC reduction at 6-month and 12-month periods? (b) Is there a correlation between HbA1C reduction and the number of the provider visits? and (c) Is there a significant HbA1C reduction for the one-on-one PHN education participants compared to the non-participants? The result findings were analyzed using the Chi-Square tests and the two-sample t-tests. On average, the 114 subjects achieved HbA1C reductions of0.57% and 0.63% at 6-month and 12-month periods, respectively. However, there was no direct correlation between the HbA1C reductions and the frequency of provider visits. Furthermore, the PHN education session(s) did not significantly affect the rate of HbA1C reduction for the attendees. In conclusion, future studies on culturally competent interventions should be studied in the Vietnamese patients diagnosed with diabetes mellitus.
Zequera, DiÌaz Martha Lucia. "A computer assisted model for orthotic management of the diabetic foot in the early stages of the disease." Thesis, University of Strathclyde, 2004. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.423862.
Повний текст джерелаWhyte, Megan. "Glycemic Control in a Type I Diabetic Athlete: Recommendations for Athletic Trainers in Management, Athlete Care, and Performance." Scholarly Commons, 2019. https://scholarlycommons.pacific.edu/uop_etds/3605.
Повний текст джерелаMcLaughlin, Gayla Diane. "Achieving Glycemic Control in Rural Clinics." ScholarWorks, 2018. https://scholarworks.waldenu.edu/dissertations/6065.
Повний текст джерелаMeashi, Hadia. "HBA1C IN NON-DIABETIC ADULTS USING NHANES 2013-2014 DATA: THE RELATIONSHIP WITH CAFFEINE, CARBOHYDRATES, AND PHYSICAL ACTIVITY." University of Akron / OhioLINK, 2018. http://rave.ohiolink.edu/etdc/view?acc_num=akron1542667283140221.
Повний текст джерелаHo, I.-Van. "The role of tele-ophthalmology as part of a community health service to remote top end Northern Territory communities cost-effectiveness study of diabetic retinopathy screening, monitoring and management /." Connect to full text, 2006. http://hdl.handle.net/2123/5432.
Повний текст джерелаTitle from title screen (viewed Oct. 7, 2009) Submitted in fulfilment of the requirements for the degree of Doctor of Philosophy to the Discipline of Clinical Ophthalmology and Eye Health, Faculty of Medicine. Includes bibliography. Also available in print form.
Bowling, Frank Lee. "The role of non-pharmacological treatments and a new wound measurement system in the management of the diabetic foot." Thesis, University of Manchester, 2009. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.506251.
Повний текст джерелаSonday, Farhaana. "Medicine therapy management for diabetic club Patients at a primary health care clinic: exploring a Potential role for pharmacists." University of the Western Cape, 2019. http://hdl.handle.net/11394/7479.
Повний текст джерелаDiabetes mellitus is a complex chronic condition and has become a major public health concern worldwide. Many diabetic patients are accessing primary health care (PHC) clinics for diabetes care. Diabetic patients who are considered stable are referred to chronic diseases of lifestyle club at the PHC facility. Effective management of this chronic condition requires a multidisciplinary team approach to diabetes care. Pharmacists are not often included in a multidisciplinary team and would consist of doctors, nurses and dieticians. Teams may be expanded and require specialist healthcare members’ expertise who can assist in the management of this disease, for example, ophthalmologists and podiatrists. Adherence to standard treatment guidelines (STGs) for the management of diabetes by healthcare professionals at a primary care level can improve glycemic control, decrease health costs and reduce the development of long-term diabetic complications.
Gambrel, Michael Steven. "Diabetic Caregiver Finance Education and Resulting Stress: A Quantitative Correlational Study." Franklin University / OhioLINK, 2021. http://rave.ohiolink.edu/etdc/view?acc_num=frank1626087352819533.
Повний текст джерелаAndersson, Simon. "Point-of-care beta-hydroxybutyrate determination for the management of diabetic ketoacidosis based on flexible laser-induced graphene electrode system." Thesis, Linköpings universitet, Sensor- och aktuatorsystem, 2021. http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-179116.
Повний текст джерелаSantos, Tânia Raquel Martins dos. "Novel therapeutic strategies for the management of diabetic foot infections : the evaluation of selected antimicrobial peptides against clinically isolated bacterial pathogens." Doctoral thesis, Universidade de Lisboa, Faculdade de Medicina Veterinária, 2020. http://hdl.handle.net/10400.5/20150.
Повний текст джерелаDiabetic foot infections (DFIs) are a frequent complication of Diabetes mellitus. These ulcers are prone to be colonized by Staphylococcus aureus and Pseudomonas aeruginosa, including multidrug resistant and biofilm-producing strains, possibly leading to DFI chronicity and amputation. New therapeutic strategies for DFI management are urgent and the antimicrobial peptides (AMPs) nisin and pexiganan are potential candidates. This project aimed to evaluate the activity of these AMPs, incorporated in a guar gum biogel, against selected DFI clinical isolates. Firstly, nisin’s activity against a collection of S. aureus DFI clinical isolates was determined. Results showed that nisin was able to inhibit and eradicate S. aureus planktonic and biofilm cells at concentrations below its acceptable daily intake. When incorporated in the biogel, nisin kept its antimicrobial activity. This work also evaluated the potential of nisin to complement the activity of conventional antiseptics and antibiotics against established biofilms formed by these isolates. An in vitro antimicrobial schematic protocol was developed to mimetize DFI management guidelines. Fifteen antimicrobial combinations, including nisin-biogel, chlorhexidine, clindamycin, gentamicin and vancomycin, were tested. Results showed that the higher levels of biofilm inhibitory effects were presented by therapeutic combinations that included the nisin-biogel formulation. Nisin-biogel ideal storage conditions and cytotoxicity were also evaluated. Results demonstrate that if stored at temperatures between -20 and 22ºC, nisin-biogel is able to maintain its antimicrobial activity up to 24 months. Moreover, after 24 h of exposition, the nisin-biogel presented no significant levels of toxicity regarding the human keratinocytes under study. Lastly, to cover the complex microbiota present in DFIs, a combination of AMPs with different action spectra was developed, based on the simultaneous incorporation of nisin and pexiganan in the biogel. The activity of this dual-AMPs formulation was tested against two S. aureus and P. aeruginosa strains isolated from the same DFI. Acting together, these AMPs were able to diffuse from the biogel and inhibit and eradicate biofilms formed by these DFI isolates. The effectiveness of AMPs, particularly nisin and pexiganan, as novel antimicrobial strategies for the management of DFIs is still an unknown territory that merits investigation. In vitro biofilm models are the basis of preliminary research; however, they underrepresent the complex microbiota present in DFIs and their interaction with the immune system and skin cells constituents. Further research is necessary to understand the AMPs full potential regarding the clinical management of biofilm-related diseases, such as DFIs.
RESUMO - As infecções do pé diabético (IPDs) são uma complicação frequente da Diabetes mellitus. Estas úlceras tendem a ser colonizadas por Staphylococcus aureus e Pseudomonas aeruginosa, incluindo estirpes multirresistentes e produtoras de biofilme, possivelmente causando cronicidade da IPD e amputação. É urgente criar novas estratégias para o tratamento das IPD e os péptidos antimicrobianos (PAMs) nisina e pexiganan são potenciais candidatos. Este projecto avaliou a actividade destes PAM, incorporados num biogel de goma de guar, contra isolados de IPD. Primariamente, foi determinada a actividade da nisina contra uma colecção de S. aureus isolados de IPD. Os resultados mostraram que a nisina é capaz de inibir e erradicar S. aureus na forma planctónica e de biofilme a concentrações abaixo da dose diária recomendada. Quando incorporada no biogel, a nisina manteve a sua actividade. Foi ainda avaliado o potencial da nisina para complementar a actividade de antissépticos e antibióticos convencionais contra biofilmes formados por estes isolados. Foi criado um protocolo que simula in vitro o tratamento convencional das IPDs. Foram testadas 15 combinações de antimicrobianos, incluindo biogel de nisina, clorohexidina, clindamicina, gentamicina e vancomicina. Os resultados mostraram que o maior efeito inibidor de biofilmes pertencia a combinações que incluam o biogel de nisina. Foram também avaliadas as condições de armazenamento ideais para o biogel de nisina e a sua citotoxicidade. Quando armazenado a temperaturas entre -20 e 22ºC, o biogel de nisina manteve a sua actividade antimicrobiana durante pelo menos 24 meses. Adicionalmente, após exposição durante 24 horas, o biogel de nisina não apresentou níveis significativos de toxicidade relativamente aos queratinócitos humanos em estudo. Por último, para abranger a complexa microbiota presente nas IPDs, foi avaliada uma combinação de PAMs com diferentes espectros de acção, baseada na incorporação simultânea de nisina e pexiganan no biogel. A actividade desta formulação foi testada contra duas estirpes de S. aureus e P. aeruginosa isoladas da mesma IPD. Conjuntamente, estes PAMs foram capazes de se difundir do biogel e inibir e erradicar biofilmes formados por estes isolados. A eficácia dos PAMs como novas estratégias para o tratamento das IPD é ainda uma área desconhecida. Os modelos in vitro de biofilmes são a base da investigação; contudo, não representam a microbiota presente nas IPD nem a sua interacção com o sistema imunitário e outros constituintes celulares. É essencial continuar a investigar para compreender o potencial dos PAMs na terapêutica de doenças onde haja formação de biofilmes, como é o caso das IPDs.
N/A
Paton, J. S. "A comparison of functional and prefabricated insoles used for the preventative management of neuropathic diabetic foot ulceration : a single blind randomised control trial." Thesis, University of Plymouth, 2008. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.504794.
Повний текст джерелаPaton, J. S. "A comparison of functional & prefabricated insoles used for the preventative management of neuropathic diabetic foot ulceration : a single blind randomised control trial." Thesis, Exeter and Plymouth Peninsula Medical School, 2008. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.701064.
Повний текст джерелаPetersen, Fazlyn. "Determinants for the acceptance and use of mobile health applications: Diabetic patients in the Western Cape, South Africa." University of Western Cape, 2019. http://hdl.handle.net/11394/7832.
Повний текст джерелаThe increased pervasiveness of information communication and technology and increasing internet access creates anticipation for how contemporary technologies can address critical developmental problems. Non-communicable diseases are the leading cause of death globally, even though more than 40% of the deaths are premature and avoidable. Diabetes is such a disease that causes 80% of non-communicable disease deaths in low and middle-income countries. Diabetes is also the leading cause of death in the Western Cape province of South Africa. Diabetes thus constitutes a challenge to achieve Sustainable Development Goal 3 that focuses on health and well-being for all people, at all ages. The potential of technology, such as the use of m-health applications, is recognised as a means to advance the Sustainable Development Goals through supporting health systems in all countries.
Beukes, Daniel Wilhelm. "How to improve diabetic care in the Wesbank/ Ilingu Lethu suburb of Malmesbury, Western Cape." Thesis, Stellenbosch : Stellenbosch University, 2010. http://hdl.handle.net/10019.1/20439.
Повний текст джерелаBibliography
Introduction: Diabetes in Africa has been described as a pandemic, with the prevalence in South Africa estimated at 4.5% of the population. Despite clear national guidelines from the Society of Endocrinology, Metabolism and Diabetes of South Africa, an unpublished quality improvement cycle in 2007 has shown poor patient knowledge with associated uncontrolled glycaemic and hypertensive control in diabetic patients in a district health system. The purpose of the study was to identify possible reasons for this and to find solutions for improving diabetic care within the Wesbank/ Ilingu Lethu suburb of Malmesbury, Western Cape. Methods: A cooperative inquiry group was established, consisting of primary health care providers at a district hospital and a primary health care clinic. The inquiry completed several cycles of action-reflection over a period of eight months, and included training in diabetic related topics and critical reflection techniques. At the end of the inquiry consensus was reached on key findings by group and learning within the group. Findings: Consensus was expressed in two key findings. The group identified and prioritized continuity of care and diabetic education key areas where diabetic care could be improved in the research population. The first was addressed by initiating diabetic registries, establishment of a regular diabetic clinic, implementation of a diabetic schedule within the medical records and the forming of a diabetic team that could support continuity of relationships, clinical management and organisation of care between both facilities. The diabetic team involved non-governmental organizations, private health providers and the community to increase awareness and develop capacity to improve diabetic care. The other finding confirmed diabetic education as a critical area in diabetic self management. The diabetic team initiated a diabetic community forum for educational and informative group activities. There was also continued professional development with education sessions within the cooperative inquiry group themselves. Conclusions: Improving diabetic care through continuity of care and education is well supported in known evidence based literature. The challenge is to translate/ transfer the available knowledge and render it operational and clinical in any health setting. The co-operative inquiry process was a valuable tool to identify, prioritized and addresses unique challenges for improving diabetic care in our specific context.
Chuma, Thandi. "A qualitative study on diabetic and hypertensive patients in Cape Town, South Africa: their experiences of primary health care and their struggles with self-management." Master's thesis, University of Cape Town, 2014. http://hdl.handle.net/11427/12818.
Повний текст джерелаThe overall aim of this study was to understand how diabetic and hypertensive patients experience PHC in Cape Town, as well as their capacity for self- management of their condition. The specific objectives were: to explore how patients react to existing health care materials/interventions at the health care facility; to identify the needs these patients have for information and behavioural change counselling; to investigate the perceived barriers to lifestyle modification in relation to the patients and to the broader social and economic environment and to investigate the sources of personal motivation to control their illness through lifestyle modification.
Myers, Valerie Harwell Herbert James D. "Mood and anxiety symptomatology in adults with insulin-dependent Diabetes Mellitus using intensive management regimens /." Philadelphia, Pa. : Drexel University, 2003. http://dspace.library.drexel.edu/handle/1860/233.
Повний текст джерелаMitev, Nikolay. "E-health for people with diabetes : Adoption and use of diabetes self-management applications among diabetics in Bulgaria." Thesis, Internationella Handelshögskolan, Högskolan i Jönköping, IHH, Informatik, 2018. http://urn.kb.se/resolve?urn=urn:nbn:se:hj:diva-39081.
Повний текст джерела